Related by context. All words. (Click for frequent words.) 77 anti botulism antibody 76 Acetavance TM intravenous acetaminophen 76 thrombin component 75 KRYSTEXXA TM pegloticase 75 Auxilium transmucosal film 75 XL# anticancer compounds 75 Idera Pharmaceuticals develops 74 topical antifungal product 74 IMPDH inhibitor 74 semi synthetic lipoglycopeptide 73 commercialize CorMedix drug 73 sapropterin dihydrochloride Phase 73 HEPLISAV ™ 73 novel L DOS# 73 AAG geldanamycin analog 73 overactive bladder AA# 73 pharmacogenomic translational research 73 dihydrochloride Phase 3 73 Crofelemer budesonide foam 73 include Phenoptin TM 72 Anturol ® 72 topical anti infective 72 Iluvien ® 72 Aganocide 72 CB2 selective receptor agonist 72 REG2 Regado 72 Kosan dependence 72 delivers fluocinolone acetonide FA 71 non nucleoside inhibitor 71 Files IND 71 pipeline GlycoPEG GCSF 71 Empatic ™ 71 polysaccharide polymer 71 TELINTRA R 71 SinuNase ™ 71 Initiates Enrollment 71 SinuNase TM novel 71 Nicotine Conjugate Vaccine 71 include GALNS N 71 Submits Biologics License Application 71 Xcytrin R 71 developing ostarine selective 71 pralatrexate injection folate analogue 71 muscarinic receptor agonist 71 VEGFR2 inhibitor 71 targeted radiotherapeutic 71 Intermezzo ® zolpidem tartrate 71 Completes Patient Enrollment 70 TRIOLEX ™ 70 M# rationally 70 Inc. www.micromet inc.com 70 using VIAdel TM 70 AN# novel 70 HepeX B TM 70 Staphylococcus aureus Immune Globulin 70 intranasal insulin product 70 ionotropic glutamate receptor antagonists 70 Initiates Phase II 70 oxybutynin ATD TM 70 developing Zerenex ferric 70 GVAX ® 70 XOMA 3AB biodefense 70 markets Testim ® 70 PNP inhibitor 70 Alfacell proprietary ribonuclease 70 developing oral talactoferrin 70 HEPLISAV Phase 70 TOCOSOL Camptothecin 70 hypoxia activated prodrug 70 selectin antagonist 70 Hematide ™ 70 generation URAT1 inhibitor 69 treats acute lymphoblastic 69 JZP 69 Prednisporin 69 ALTROPANE R 69 Telik logo TELINTRA 69 Hematide TM 69 Initiates Clinical 69 oral prodrug 69 Zemiva TM 69 modified glutathione analog 69 PDX pralatrexate 69 oncolytic virus therapies 69 Veronate R 69 triggers apoptosis programmed 69 oral dihydropyrimidine dehydrogenase DPD 69 acetylgalactosamine 6 69 muscarinic receptor agonists 69 Submits NDA 69 clinical trials Archexin 69 lintuzumab SGN 69 TRIOLEX HE# APOPTONE HE# 69 Pruvel TM 69 Begins Dosing 69 next generation URAT1 69 dimebon latrepirdine 69 IMiDs R 69 R MSCRAMM 69 proprietary intranasal insulin 69 Nasulin ™ 69 R sorafenib tablets 69 faropenem medoxomil 69 clinical trials dacetuzumab SGN 69 botulism antibody 69 active cellular immunotherapy 68 Initiates Clinical Trial 68 Personalized Immunotherapy 68 oral proteasome inhibitor 68 DIFICID ™ 68 SPL# Gel vaginal microbicide 68 Zemiva TM Trofex TM 68 proprietary Isolagen Process 68 Aganocide ® 68 REMOXY POSIDUR ELADUR 68 virus HCV protease inhibitor 68 molecular imaging radiopharmaceutical 68 novel MetAP 2 68 PROVENGE ® 68 IgG1 monoclonal antibody 68 initiated Phase Ib 68 Dendreon investigational 68 infectious diseases autoimmune 68 Trofex TM 68 MKC# MT 68 HCV RNA polymerase 68 Trubion proprietary 68 highly purified pasteurized 68 sapacitabine CYC# 68 proprietary HuCNS SC 68 synthetic anti infective 68 Solazed TM 68 palifosfamide Zymafos TM 68 Nventa proprietary CoVal 68 lead molecular radiotherapeutic 68 leading oral taxane 68 Receives Fast Track 68 PLK1 SNALP 68 candidate AQ4N 68 motexafin gadolinium Injection 68 estrogen receptor beta agonist 68 CYT# vascular disrupting 68 candidate deforolimus 68 mitogen activated ERK kinase 68 omecamtiv mecarbil formerly 68 autologous cellular immunotherapy 68 HEPLISAV TM 68 MOVIPREP R 68 non porcine pancreatic 68 ACAPODENE TM 68 developing ACAPODENE 68 sores onychomycosis nail 68 novel emulsion formulation 68 IMiDs ® 68 Zemiva ™ 67 Receives Approvable Letter 67 Micromet proprietary BiTE 67 Receives Orphan Drug 67 infectious diseases autoimmune diseases 67 NU# direct 67 subsidiaries visit http:/www.apricusbio.com 67 vi Immtech ability 67 topically applied SEPA 67 Romidepsin 67 oral isotype selective HDAC 67 RH1 targeted chemotherapeutic agent 67 include Altastaph TM 67 4SC AG ISIN DE# 67 TNFerade ™ 67 biomimetics non 67 ATRA IV 67 phenylalanine ammonia lyase 67 please visit www.medicinova.com 67 THR beta agonist 67 Initiates Dosing 67 toenail onychomycosis 67 StaphVAX R 67 Prednisporin TM 67 FOLOTYN ® 67 R bortezomib 67 molecular therapeutics immunotherapies 67 romidepsin novel 67 apricitabine ATC 67 zolpidem tartrate sublingual tablet 67 AzaSite ISV 67 Budesonide foam crofelemer 67 humanized therapeutic 67 reformulates existing FDA 67 PDE4 inhibitor 67 XP# XP# 67 Archexin 67 Peyronie disease Frozen Shoulder 67 BiovaxID TM 67 CEQ# 67 XOMA 3AB 67 Pruvel ™ prulifloxacin 67 HuMax TAC 67 please visit http:/www.vandapharma.com 67 please visit www.middlebrookpharma.com 67 Presents Positive 67 product platforms AZX# 67 agonistic human 67 LEVADEX TM 67 Panzem R 67 DOS# 67 Empatic TM 67 PORxin TM 67 Therapeutic Competitors Companies 67 topical gel formulation 67 PEG PAL PEGylated recombinant 67 Anidulafungin 67 PANVAC VF 67 * olmesartan medoxomil 67 Unit Dose Budesonide 67 Oral NKTR 67 drug GLPG# 67 successfully commercialize Iluvien 67 visit www.targanta.com 67 candidate TNFerade biologic 67 Presents Preclinical Data 67 Solazed 67 Zoraxel TM 67 www.nanoviricides.com 67 Submits Response 67 JAK2 Inhibitor 67 pan histone deacetylase 67 TLR9 agonist IMO 67 cladribine Cladribine Tablets 67 topical non steroidal 67 RANK Ligand inhibitor 67 FDA Accepts 67 Oral Calcitonin 67 oral ghrelin agonist 67 TRACON Pharmaceuticals 67 OAB overactive bladder 67 oxybutynin ATD ™ 67 folate analogue metabolic 67 TM Aganocide 67 Submits Supplemental 67 non nucleoside HCV 67 valtorcitabine 67 solid tumors ZYBRESTAT 66 Synavive ™ 66 CEL SCI Phase III 66 Kuvan TM sapropterin 66 Zenvia ™ 66 Granted Orphan Drug 66 LibiGel ® testosterone gel 66 Amgen Kyowa Hakko Kirin 66 Generx TM 66 investigational humanized monoclonal antibody 66 EVIZON TM squalamine lactate 66 Meets Primary Endpoint 66 IG HCR ;) CO 66 developing Surfactant Replacement 66 Successfully Completes Phase 66 Cannabinor 66 Corp. www.anavex.com 66 OvaRex R 66 Submits IND 66 ® bortezomib 66 neuropathic pain metabolic diseases 66 Vaccine Adjuvant 66 candidates Azedra TM 66 defensin mimetic antibiotic 66 Daclizumab 66 Silenor ® doxepin 66 GlycoPEGylated hemostasis compounds 66 Kosan proprietary 66 trastuzumab DM1 T DM1 66 developing Zerenex TM 66 HCV polymerase 66 TOCOSOL R 66 3 registrational trial 66 Pruvel 66 Initiates Phase III 66 Trofex ™ 66 Civacir TM Hepatitis C 66 Antibody Drug Conjugate 66 candidate ATHX 66 IV APAP 66 indications Cytokinetics 66 oral picoplatin 66 KRYSTEXXA TM 66 5 HT3 antagonist 66 MAGE A3 ASCI 66 include Alferon N 66 CMV vaccine 66 LibiGel ® 66 TransVax ™ 66 targets Galectin receptors 66 peripherally acting 66 AN# topical anti 66 erlotinib Tarceva R 66 Pruvel ™ 66 targeted anticancer biopharmaceuticals 66 markets HP Acthar 66 metastatic carcinoid 66 NicVAX TM 66 TKB# 66 TBC# 66 orBec ® oral beclomethasone 66 Files Investigational 66 patented DepoVax TM 66 forodesine hydrochloride 66 DPX Survivac 66 Receives Orphan Drug Designation 66 investigational pharmacologically unique 66 GVAX R 66 PrevOnco 66 6 sulfatase 66 Vitrasert R 66 Aflibercept 66 Emergent marketed 66 molecular chaperone regulation 66 novel synthetic PEGylated 66 ABL inhibitor 66 PEGylated docetaxel 66 Prodarsan R 66 markets COLAZAL 66 adecatumumab MT# 66 acetonide FA 66 addressing idiopathic pulmonary 66 endoscopic autofluorescence imaging 66 Initiate Clinical Trial 66 Maxy G# 66 PEG irinotecan 66 ILUVIEN ® 66 MT#/MEDI-# 66 Trastuzumab DM1 66 ASONEP TM 66 CYP#A# isoenzyme 66 Provectus Pharmaceuticals specializes 66 SinuNase TM 66 fibrosis IPF 66 signal detection CTSD 66 Announces Tentative Approval 66 novel orally inhaled 66 inflammatory PDE 66 Exherin 66 XL# XL# 66 R#/MEM # 66 cosmetic cosmeceutical products 66 Custirsen 66 compound ISA# 65 MKC# MKC# PP 65 novel histone deacetylase 65 Presents Preclinical 65 injectable investigational 65 MT# MEDI 65 Medidur ™ FA 65 recombinant PSMA vaccine 65 BEMA Granisetron 65 Peginterferon alfa 2b 65 VitiGam 65 selective estrogen receptor modulator 65 E CENP E 65 IL# PE#QQR 65 pentadentate logo R 65 Idera Pharmaceuticals 65 acyclovir Lauriad R 65 dasatinib Sprycel ® 65 NEBIDO VANTAS SUPPRELIN LA 65 mertansine 65 platform HDL Mimetic 65 personalized dendritic 65 dacetuzumab SGN 65 MKC# 65 Albuferon albinterferon alfa 2b 65 MSCRAMM ® 65 DNA methyltransferase inhibitors 65 Aeolus Pharmaceuticals Announces 65 gastro intestinal inflammation 65 ASONEP ™ 65 Omigard TM omiganan pentahydrochloride 65 ALN PCS 65 commercializing oxidized glutathione 65 Vitamin D analogue 65 INTEGRILIN R eptifibatide Injection 65 Initiate Phase III 65 Excellarate TM 65 Completes Enrollment 65 SUTENT ® 65 Acetavance TM 65 Vertex hepatitis C 65 receptor inhibiting monoclonal 65 Levulan ® PDT 65 recombinant biopharmaceutical 65 Tarmogen 65 including eniluracil ADH 65 ALN TTR# 65 ix Immtech ability 65 Panzem R NCD 65 sorafenib tablets 65 OTC BB PVCT 65 Hedgehog Pathway Inhibitor 65 secretory phospholipase A2 65 R roscovitine 65 rxRNA 65 delivery polymer matrix 65 product candidate Lpathomab 65 Exelixis compounds 65 2 methoxyestradiol 65 proven DuraSite ® 65 candidate XP# 65 potentially treat nephropathic 65 novel VDA molecule 65 Accelerated Intelligent 65 TransVax tm 65 monoclonal antibody IgG1 Mab 65 androgen receptor modulator 65 MCSP respectively 65 SILENOR TM doxepin HCl 65 5 HT2A inverse 65 generation PNP inhibitor 65 HCV NS5B polymerase 65 Chimigen TM 65 Maribavir 65 Universal Pandemic Influenza 65 Reports Preclinical Data 65 LymphoStat B belimumab 65 http:/www.sunesis.com 65 Silodosin 65 CYP#A# CYP#D# 65 Fx #A 65 Oracea TM 65 stage antibody MT# 65 candidate MyVax 65 candidate AP# 65 technology visit http:/www.genmab.com 65 Merck OSI Pharmaceuticals 65 rusalatide acetate 65 5 lipoxygenase activating 65 By JAMAAL ABDUL 65 pan BCR ABL 65 therapeutic monoclonal antibody 65 commercialize OncoGenex lead 65 Second Pivotal Phase 65 orBec R oral beclomethasone 65 Ferring Pharmaceuticals specializes 65 Luramist TM 65 candidate SILENOR TM 65 Cardium Therapeutics TM 65 INSPIRE Trial Phase III 65 small molecule Hedgehog 65 evaluating picoplatin 65 Commences Phase 65 ELADUR TM 65 Phase 2b Clinical Trial 65 oral immunomodulatory 65 CD# CEA 65 International LAB Pharma 65 Asentar TM 65 metaglidasen 65 PORxin TM platforms 65 OTCBB URGP specialty 65 brand ciclesonide HFA 65 cancer indications bafetinib 65 midstage clinical 65 JOULFERON 65 Receives Milestone Payment 65 superparamagnetic iron oxide nanoparticles 65 intravesical infusion therapy 65 peptidic compound 65 Anturol TM 65 CytRx oncology 65 TKM PLK1 65 cathepsin K inhibitor 65 investigational monoclonal antibody 65 Neo Kidney Augment 65 #/#/# Cytokinetics Incorporated 65 Alzheimer disease cognitive dysfunction 65 Cardio Vascu Grow 65 CORT # estimates 65 Naglazyme R 65 L Annamycin 65 programs visit http:/www.bionovo.com 65 Allovectin 7 65 Phase #b/#a clinical 64 accumulate preferentially 64 OMAPRO ™ 64 NS5b 64 include PLX IBD 64 personalized cellular immunotherapy 64 GERD migraine headaches 64 Sangamo ZFP TF 64 Tesetaxel 64 website www.celsion.com 64 dependent kinase inhibitor 64 ACEON R perindopril erbumine 64 includes TOLAMBA TM 64 novel therapeutic antibodies 64 Application BLA 64 Nanobody R 64 pafuramidine maleate 64 Hsp# Inhibitor 64 coronary stent merged 64 Bellicum 64 treat chronic sinusitis 64 small molecule glucokinase 64 BiTE R 64 ovarian cancer chronic hepatitis 64 Cloretazine ® 64 Receive Milestone Payment 64 Miraxion Amarin lead 64 Inc Therapeutic Competitors 64 torezolid phosphate 64 Surfaxin LS 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 HGS ETR1 mapatumumab 64 drug pipeline TAFA# 64 BioGlue R 64 lead Aganocide compound 64 Besivance 64 BioGlue ® 64 Potelligent Technology 64 ® decitabine 64 TM pralatrexate injection 64 Predictive medicine 64 IMA# 64 methylnaltrexone bromide 64 RESTORE CLI trial 64 CYCLOSET ® 64 AVAX AC Vaccine 64 nano particle tumor suppressor 64 XL# XL# XL# XL# 64 Glufosfamide 64 Cyclooxygenase Inhibiting Nitric Oxide 64 Pegloticase 64 visit www.sciclone.com 64 liposomal formulation 64 dutogliptin 64 investigational hepatitis B 64 Onyx Pharmaceuticals Announces 64 seliciclib CYC# 64 NYSE Amex NBY clinical 64 sNDAs 64 TÎ ² 4 64 TRANSDUR ™ 64 dextromethorphan quinidine 64 please visit http:/www.atherogenics.com 64 diarrhea predominant irritable 64 BHT DNA 64 CCR9 antagonist 64 anti CD3 monoclonal 64 non thiazolidinedione TZD 64 sorafenib tablets small 64 Perflubutane Polymer Microspheres 64 delta gamma agonist 64 please visit http:/www.sunesis.com 64 immunosuppressant therapies 64 Amigal TM 64 ospemifene 64 orally administered inhibitor 64 orally inhaled migraine 64 Neo Urinary Conduit 64 Augment TM 64 visit www.genenews.com 64 MAb therapy 64 Dyax logo 64 sulfonylhydrazine class 64 Mylan Receives Approval 64 TRANSDUR ® 64 clinical trials Archexin ® 64 PRN FDA Approves 64 Demonstrates Positive 64 Namenda Memantine HCl 64 fusion enhancers 64 please visit www.sucampo.com 64 non peptidic protease 64 Nabi HB Intravenous 64 www.oxigene.com 64 developing adecatumumab 64 palonosetron hydrochloride Injection Dacogen 64 HYVISC ® treatment 64 Through Glycoscience R 64 Levoleucovorin 64 R vitespen 64 OTC BB PVCT http:/www.pvct.com 64 Linjeta TM 64 Spiegelmer ® 64 intravenous iclaprim potent 64 Troxatyl 64 Iluvien TM 64 selective A2A adenosine receptor 64 refractory chronic lymphocytic 64 GSK '# 64 CysDisplay R 64 topical antifungal 64 selective immunoproteasome inhibitor 64 Testosterone MDTS ® 64 peptibody 64 Pancreate 64 CD4 monoclonal antibody 64 www.vivus.com 64 IMiDs ® compound 64 Elagolix 64 Darinaparsin Zinapar TM 64 CYT# potent vascular disrupting 64 recurrent metastatic ovarian cancer 64 diagnostic molecular imaging 64 histamine dihydrochloride 64 evaluating satraplatin 64 Ecallantide 64 VitiGam TM 64 progressive metastatic prostate 64 Trofex 64 www.syntapharma.com 64 ZFP Therapeutics 64 oral nucleoside analogue 64 Allovectin 7 r 64 Belimumab 64 histone deacetylase HDAC inhibitor 64 tivozanib AV 64 candidate oral AP# 64 Exalgo TM 64 CCR5 mAb 64 Panflu TM 64 Inc. NASDAQ TRGT 64 Phase Ib clinical trials 64 Solzira TM 64 Pentad TM 64 Evoltra ® 64 SYCREST 64 multi kinase inhibitor 64 Zalypsis 64 TransVax TM 64 oral beclomethasone dipropionate 64 Opterone R 64 Xeloda ® 64 novel proprietary KL4 64 R memantine HCl 64 Achieves Primary Endpoint 64 non nucleoside polymerase 64 AAG KOS 64 platinum chemotherapeutic 64 prostate cancer antigen prostatic 64 var arrContent = 64 Trial Evaluating 64 Entereg R 64 generation DACH Platinum 64 platforms GVAX 64 novel immunotherapies 64 Solzira ™ 64 serious systemic Staphylococcal 64 commercialize becocalcidiol patented 64 Aradigm Logo 64 BLyS specific 64 Inc. Nasdaq OXGN 64 Affilin ® 64 Crizotinib PF # 64 Phase III Pivotal 64 individualized cellular immunotherapy 64 DP VPA 64 Biologic License Application BLA 64 AdVac ® 64 Oral Suspension USP 64 Submits Investigational 64 humanized interleukin 6 64 Pain Neutralizer holds 64 Cinryze TM C1 inhibitor 64 Sphingomab TM 63 small molecule thrombopoietin 63 Hematide ™ peginesatide 63 markets Gelclair R 63 HuCNS SC ® 63 TELINTRA 63 Angiocept 63 Initiates Phase 63 OTCBB PYTO 63 BioSante Pharmaceuticals Announces 63 BCG refractory carcinoma 63 oral Janus kinase 63 proteasome inhibitor 63 clinical trials lintuzumab SGN 63 GALNS N acetylgalactosamine 63 Panzem NCD 63 Androxal TM 63 Aztreonam 63 Initiate Phase 63 PEGylated Fab fragment 63 HGS ETR2 63 Thalomid R 63 RAS MAPK pathway 63 LEVADEX ™ 63 commercialize deforolimus ARIAD 63 novel topoisomerase 63 vapreotide acetate 63 Bayer HealthCare Onyx Pharmaceuticals 63 immunotherapeutic agent 63 MediGene focuses 63 liver resection surgeries 63 Earns Milestone Payment 63 Additionally Keryx 63 diabetes irritable bowel 63 particularly SANCTURA XR 63 COLAZAL R 63 histone deacetylase HDAC 63 Intravenous Human 63 candidate CRLX# 63 AcryMed technologies 63 Perforomist TM formoterol fumarate 63 class mGluR5 inhibitor 63 anti VEGF aptamer 63 PrevOnco ™ 63 PROVENGE sipuleucel T 63 Inc. AMEX YMI 63 IND submission 63 symbol AVXL 63 RNAi Therapeutic 63 SynCon ™ DNA 63 Humanized Anti 63 Tezampanel 63 taxane derivative 63 QNEXA ® 63 Shigamabs ® 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 include ClindaReach TM 63 negative allosteric modulator 63 Licenses Novel 63 Polymer Microspheres 63 Annamycin 63 polymer conjugate technology 63 Vicriviroc 63 Azedra TM 63 Valortim TM 63 NASDAQ SNTA 63 E2F Decoy 63 Civacir 63 ocular formulation 63 Allovectin 7 R 63 Randomized Double blind 63 Ustekinumab 63 Chemokine Therapeutics 63 generation Hsp# inhibitor 63 ABL inhibitor completing 63 Talabostat 63 Pivotal Phase 63 HCV NS3 protease 63 rHuPH# recombinant human 63 novel immunomodulatory 63 Selzentry Celsentri 63 neuro inflammatory disorders 63 candidate bevirimat PA 63 Panzem 63 Ostarine ™ 63 Ferumoxytol 63 Ovitrelle R Serostim 63 Qutenza TM 63 migraine headaches neuropathic pain 63 targeting Inflammatory Bowel 63 DepoCyt ® Abelcet ® 63 EVIZON ™ 63 Fibrillex TM 63 PREOS R 63 accessories autologous 63 Please visit www.antisoma.com 63 herpes labialis cold 63 Rhucin ® recombinant 63 oral ferric iron 63 HDL Mimetic Peptide 63 vaginally administered lidocaine 63 CombinatoRx Incorporated 63 dihydrochloride Tablets 63 OctoPlus licensed 63 PDE# 63 Fodosine 63 M Enoxaparin 63 KRN# 63 MEDAREX 63 novel tubulin binding 63 manufactures minimally invasive 63 Lenocta TM sodium stibogluconate 63 SynCon TM DNA 63 sterile lidocaine patch 63 Salix Pharmaceuticals Announces 63 kidney urologic 63 induced mucositis 63 hypoxia selective 63 enhance ApoA 63 CDK cyclin dependent 63 Nasdaq ACHN 63 corticotropin injection 63 IAP inhibitor 63 phase III isavuconazole 63 read Palintologist 63 Gentamicin Surgical Implant 63 inflammatory autoimmune diseases 63 Anticalin R 63 NPC 1C 63 Nasdaq ENMD 63 zileuton injection 63 ARRY # 63 candidates Azedra 63 ALN TTR 63 class anticancer quinolone 63 telomerase therapeutic 63 label Lipofen R 63 neuropathic pain spasticity 63 Polyphenon ® E 63 treat nephropathic cystinosis 63 investigational hepatitis C 63 var arrMeta = 63 angina nausea 63 Omigard TM 63 MEK Inhibitor 63 vii Cubist ability 63 Elestrin ® 63 LX# LX# LX# 63 novel anti infective 63 targeted antifolate 63 SCIB1 63 active AKT inhibitor 63 topical ophthalmic 63 OcuGene glaucoma genetic 63 R sipuleucel T 63 Loramyc TM 63 Capsulitis 63 RECOTHROM ® 63 Inc. NASDAQ IDIX 63 Enhanze TM Technology 63 opioid bowel dysfunction 63 Quinamed R 63 candidate ridaforolimus 63 Bioral Amphotericin B. 63 mGluR5 NAM 63 Optiquel ™ 63 TO AVOID PREGNANCY WHILE 63 GATTEX TM 63 www.ucb group.com 63 Announces Poster Presentations 63 OTCBB HXBM developer 63 nasal decolonization 63 Frozen Shoulder syndrome Adhesive 63 LHRH antagonist 63 candidate Hematide TM 63 BRILINTA 63 ThermoDox ® clinical 63 triple VEGF receptor 63 triciribine phosphate monohydrate 63 please visit www.abraxane.com 63 concerning CombinatoRx 63 AzaSite Plus 63 var arrUrl = 63 Omacetaxine 63 JAK inhibitor 63 oral talactoferrin 63 Janis Joplin soundalike respiratory 63 NRGN 63 commercialize XP# 63 Boehringer Ingelheim MedImmune 63 SIX RO ROG 63 please visit www.cpexpharm.com 63 Palifosfamide Zymafos TM 63 Aloprim TM allopurinol sodium 63 EHT AGN 63 Nasdaq HALO 63 Testosterone MDTS R 63 Arno Therapeutics 63 Present Preclinical Data 63 Horizant ™ 63 Augment ™ 63 includes AstraZeneca Accolate 63 submitted Biologics License 63 Inc. Nasdaq MITI 63 Nasdaq CLDX 63 Somatuline Depot 63 nucleotide polymerase inhibitor 63 investigational pan BCR 63 evaluating intravenous picoplatin 63 perifosine novel potentially 63 expanded autologous cellular 63 VISICOL R 63 Oxytrex TM 63 HEPLISAV TM hepatitis B 63 proprietary bioresorbable polymer 63 Drug Candidate 63 include Healive TM 63 Phase III Clinical Trial 63 BEMA ® 63 selective androgen receptor modulator 63 targeted immunotherapies 63 recombinant protective 63 Investigational Oral 63 Patient Enrollment 63 Announces Dosing 63 XSSE OXGN 63 please visit www.dyax.com 63 novel oral anticoagulant 63 NOTE POSIDUR ™ 63 Biopharmaceuticals AG 63 iSONEP ™ 63 evaluating tivozanib 63 Ostabolin C TM 63 developing TB4 63 Novel Antibiotic 63 Ceplene TM 63 recombinant subunit vaccine 62 evaluating bafetinib 62 TRX1 62 syndrome overactive bladder 62 www.combinatorx.com 62 IMPACS R 62 Immunotherapeutic 62 Inc. OTCBB BVTI 62 LEVADEX orally inhaled 62 HepDirect R 62 HepeX B 62 Tibotec BVBA 62 alvespimycin 62 Lenocta TM 62 NYSE Amex YMI 62 Initiates Phase 2b 62 miconazole Lauriad 62 Nektar proprietary 62 R daptomycin 62 Telik Announces 62 Staphylococcus aureus Polysaccharide Conjugate 62 Nasdaq IDIX biopharmaceutical 62 GlaxoSmithKline Kyowa Kirin 62 Additionally Soligenix 62 PI3K/Akt pathway inhibitor 62 developing KL4 surfactant 62 ADVANCE ILLUMINATE 62 relapsed leukemia 62 Unanimously Recommends Approval 62 Familial Adenomatous Polyposis FAP 62 omacetaxine mepesuccinate 62 R roscovitine CDK cyclin 62 Pharma Merck Serono 62 apoptosis inducer 62 Suppository Hydrocortisone Acetate Rectal 62 antibiotic candidate Ramoplanin 62 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 62 rALLy clinical trial 62 P#X# antagonist 62 itraconazole Sporanox 62 certain protein tyrosine 62 Nexavar ® 62 ENABLE Phase 2 62 specific CCR9 antagonist 62 Kuvan R 62 Inotek Pharmaceuticals Corporation 62 HCD# [002] 62 HuLuc# 62 Dementia Related Psychosis 62 Nasdaq HALO biopharmaceutical 62 SPRYCEL ® 62 BUPHENYL R 62 GATTEX ® 62 aldehyde dehydrogenase ALDH2 deficiency 62 Lisofylline LSF 62 Other ImmunoGen collaborative 62 R lenalidomide 62 data management Clintrial 62 Kinase Inhibitor 62 Cinryze ™ 62 hyaluronidase enzyme 62 intranasal formulation 62 technology Parthenogenesis 62 Albugon 62 allosteric modulator PAM 62 OMP #R# 62 Aztreonam lysine 62 ENMD # 62 dermatology therapies 62 radiation sensitizer 62 LymphoStat B TM 62 CAMPATH R 62 sodium glucose transporter 62 D aspartate NMDA receptor 62 Cethrin R 62 please visit www.advaxis.com 62 NeurogesX Nasdaq NGSX 62 Duromist ™ 62 Simulect 62 compound CMX# 62 HDL Selective Delipidation 62 Nasdaq AEGR 62 ELADUR ™ 62 utilizes InSite Vision 62 investigational oral inhibitor 62 HDAC Inhibitor 62 Omigard 62 APC Targeting Technology 62 developed preclinically 62 Aurora kinase inhibitor 62 OMNARIS HFA 62 PresbyLens ® 62 small molecule chemotherapeutic 62 Anti Tumor 62 mesylate tablets approved 62 ALVESCO R 62 targeting CD# 62 vinorelbine tartrate 62 systemic RNAi therapeutic 62 Launches Generic Version 62 doxepin HCl 62 Fibrin Patch